Salud

MDMA Therapy Setback: Journal Retracts Study After FDA Rejects Drug

MDMA Therapy Setback: Journal Retracts Study After FDA Rejects Drug

Three research papers exploring MDMA-assisted therapy for PTSD have been retracted by the journal Psychopharmacology. This follows the recent rejection of MDMA for this use by the Food and Drug Administration (FDA). The retracted studies, written by researchers affiliated with Lykos Therapeutics, the company behind the rejected treatment application, were found to involve unethical conduct at one of the research sites. Lykos, however, maintains that the retracted research was not part of their submission to the FDA. This development adds another layer of complexity to the ongoing debate over MDMA-assisted therapy. While some research suggests its potential in treating PTSD,…
Read More
Blood Clotting Risk Doubles With Erythritol Consumption: Insights From Pilot Study

Blood Clotting Risk Doubles With Erythritol Consumption: Insights From Pilot Study

A recent pilot study found that drinking a beverage containing erythritol (an artificial sweetener used to boost the content of stevia and monk fruit and to sweeten low-carb ketogenic products) more than doubled the risk of blood clots in 10 healthy individuals. Blood clots can break off from blood vessels and travel to the heart, triggering a heart attack, or the brain, causing a stroke. Previous research has linked erythritol to an increased risk of stroke, heart attack, and death. Dr. Stanley Hazen, lead author of the study and director of the Cardiovascular Diagnostic and Prevention Center at the Cleveland…
Read More
The importance of early cancer diagnosis in saving lives and reducing treatment costs

The importance of early cancer diagnosis in saving lives and reducing treatment costs

Early detection of cancer is critical to saving lives and mitigating the financial burden associated with treating this disease, health officials say. Understanding the mechanisms underlying this diagnosis becomes increasingly crucial as the incidence of cancer shifts to younger age groups, as highlighted in a report released in January by the American Cancer Society. The report, published in CA: A Cancer Journal for Clinicians, reveals a troubling trend: While the general population in the United States is aging, individuals under age 50 are experiencing an increase in overall cancer incidence from 1995 to 2020. This contrasts with older age groups,…
Read More
Breakthrough peanut allergy treatment program launched in Australia

Breakthrough peanut allergy treatment program launched in Australia

In a groundbreaking initiative, infants with peanut allergies across Australian hospitals will now have access to a life-changing treatment program aimed at building tolerance to this common allergy. The pioneering program, the first of its kind in the world, is a collaboration between the National Centre of Excellence in Allergy (NACE) and the Murdoch Children's Research Institute (MCRI). Known as the ADAPT OIT Program, it is tailored for infants under 12 months who have been diagnosed with a peanut allergy and are under the care of allergy specialists at ten children’s hospitals in five states in Australia. The treatment, provided…
Read More
Parkinson’s expert makes frequent visits to the White House for eight months

Parkinson’s expert makes frequent visits to the White House for eight months

According to official visitor logs, a Parkinson’s disease expert from Walter Reed National Military Medical Center visited the White House eight times over an eight-month period from last summer to last spring, and met at least once with President Biden’s doctor. The expert, Dr. Kevin Cannard, is a neurologist specializing in movement disorders who recently published a paper on Parkinson’s. The logs, released by the White House, document visits from July 2023 to March of this year. More recent visits, if any, would not be disclosed until later, according to the White House’s voluntary disclosure policy. It is unclear whether…
Read More